Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Ann Surg Oncol. 2019 Oct 10;27(1):156–164. doi: 10.1245/s10434-019-07626-y

FIG. 2.

FIG. 2

Kaplan–Meier analysis for overall survival in the validation cohort stratified by a completeness of cytoreduction (CCR 0/1: n = 813, CCR 2/3: n = 120) and b score group within the incomplete-cytoreduction risk score (zero: n = 62, low: n = 175, high: n = 32)